Document:

Exhibit 10.12

 Exhibit 10.12 
 Distributor Agreement 
 Party A: Beijing Dehaier Medical Technology
Co., Ltd. 
 Party B: 
 I General Rules 
  

	1.	A. Based on equal and mutual benefit, Party A and Party B sign this agreement with the aim of authorizing Party B as the distributor of
                     (product name) manufactured by Party A in the year
                    . 

  

	2.	According to different limits of authority, distributors can be divided as general distributors and exclusive distributors. 

  

	 	a.	General distributor: Party A authorizes Party B to distribute certain type or certain range of products from Party A in certain area, while this does not rule out the
possibility that Party A authorize other distributors to distribute that type or range of products in that area. 

  

	 	b.	Exclusive distributor: Party A authorizes Party B to exclusively distribute certain type or certain range of products from Party A in certain area, while Party A will
not authorize other distributor to distribute that type or range of products in that area, however, Party B has to order in time and accomplish certain amount of sales volume within certain period of time. 

  

	3.	Both Party A and Party B will not bear any legal liabilities caused by commercial activities, legal activities and operating loss of each other.

  

	4.	Party B has the right and obligation to evaluate operations of Party A (including distribution, market and commercial activities) and give suggestions. Party A should
reply in time and modify its defects and limitations. 

  

	5.	Party B should acquire necessary legal documents for distributing the products and provide a copy of corporate business license, tax registration certificate and
registration certificate for medical devices with official seal. Party B should ensure the authenticity of the documents and go through yearly check in time. If there is any problem with the qualification of Party B, Party B should bear the loss or
effect on Party A. If there is any change of above items, Party B should provided Party A in written form in time and provide new certificate. 

  

	6.	Both Party A and Party B should follow the rules in this agreement and supervise each other with the aim of better fulfilling of the agreement.

 II Product name, model and related configurations of the products distributed by Party B: 
  
  
  
  
  
  

 III Validity of Party B’s dealership 
 Validity of this agreement is from
            /             /            to
            /            /            .

 IV Distributing Area: 
  
  
 V Type of dealership 
 Party A authorizes Party B as its (exclusive/ general) distributor, thus Party B should explain to its customers while selling products from Party A,
otherwise Party B should bear the legal liabilities. Party A will take the “order confirmation sheet” as the basis of delivery. If there is any difference between this agreement and the “order confirmation sheet”, please subject
to the “order confirmation sheet”. 
 VI Business indicators and settlement price of Party B 
  

	1.	Business indicator means the committed ordered quantity or sales volume of Party B in certain period of time. 

  

	2.	The committed ordered quantity of Party B within the validity of its dealership in above mentioned area
is                                         
                                       .

  

	3.	Only after Party A receives 100% payment from Party B, the ordered quantity or sales volume will be taken as Party B’s sales performance. 

 

	4.	Evaluation of sales performance: once per season, that means Party B should order (quantity of goods)
             per season. 

 VII Price System 

Party B should strictly follow the price rules listed below, otherwise Party B should be considered defaulting and bear related responsibility. For the
first time, Party A will inform Party B in written form, while for the second time, Party A will charge Party B RMB5, 000 for defaulting. Party B’s qualification of dealership will be deprived in the third time. 
  

	1.	If the price of the product changed within the validity of Party B’s dealership, Party A should inform Party B 10 days in advance in written form.

  

	2.	Party B should not break the price system of Party A. If Party B needs to lower the price, it should apply to Party A in written form. 

  

	3.	Party A has the righting of pricing. Both Party A and Party B should take pricing information as commercial secretes. 

  

	4.	Prices of the products distributes by Party B including: settlement price, minimum distribution price, minimum retailing price, guide price and public quoted price.

 VIII Term of Payment 
 Party A accepts T/T, cash and check, while Party A will only deliver goods after received 100% payment. 
 IX Account of Party A and Party B 
  

			
	Party A:	  	Beijing Dehaier Medical Technology Co., Ltd.
	Bank of deposit:	  	ICBC Changping Branch
	Account No.:	  	0200048909200026904

 Party B: 
 Bank of deposit: 
 Account No.: 
 X Installation, Check and Maintenance of Products 
  

	1.	Within 3 days after Party B received products mentioned in this agreement, engineers with Party A will be responsible for production installation and on-site guidance.

  

	2.	Warranty period of the products is one year, while life-long maintenance will be chargeable. 

  

	3.	After sale service will be responsible by Party A. 

 XI Obligations and Responsibilities of Party A and Party B 
 A. Obligations and Responsibilities of Party A 

 

	1.	Provide products brochure; 

  

	2.	Provide support to Party B during the ordinary sales, including human resource, information, etc.; 

  

	3.	Keep Party B with the latest products information and sales policies; 

  

	4.	Products training and market support; 

 B.
Obligations and Responsibilities of Party B 
  

	1.	During the term of this agreement, Party B can not sell competitive products; 

  

	2.	Do not disclose the content of this agreement; 

  

	3.	Report to Party A about the market dynamic of competitors; 

  

	4.	Can not sell products across district without written permition of Party A; 

  

	5.	Provide full customers information; 

  

	6.	Can not do any hostile competive sales activities; 

  

	7.	Report to Party A the biding information in Party B’s district. 

  

	8.	If the customer need to investigate the situation of the products, Party B should notice Party A in advance for arrangement. 

 XII Market Support and Products Training 
 A. Market Support 
  

	1.	This support is for the exhibitions, promotion events and academic meetings in the sales area belongs to Party B. 

  

	2.	Party B will pay their own fees if Party B decide to join the above said events. Party A can decide whether provide product models for Party B according to the market
requirement and Party B should pay the logistic fee. 

  

	3.	If Party B need Party A to provide technical support, all the related fees belong to Party A. 

 B. Products Training 
  

	1.	The training is Party A’s responsibility. 

  

	2.	The products training will be divided into 4 parts and will be finished in 4 months. 

  

	3.	Before the due date, if Party B require more training content and times, they must provide written applications. 

 C. Duties and Responsibilities of the Party A 
  

	1.	Marketing Dept: response to the products exhibitions and trainings; 

  

	2.	District Managers: Manage and coordinate the distributors in the same district, responsible for the training of sales skill; 

  

	3.	Offices: Coordinate the ordinary sales of Party B and supervise the sales volume promised by Party B. Provide materials and technical support to the sales of Party B
and provide the initial products training. 

  

	4.	Party B can provide advice to Party A and ask for assistance. 

 XIII Others 
  

	1.	There are attachments to this agreement for the above items. 

  

	2.	These attachments is a part of this agreement and have the same legal validation. 

  

	3.	Each of party A and party B holds one copy of this agreement which will be validated after been signed and stamped. 

 Party A: Beijing Dehaier Medical Technology Co., Ltd. 
 Party B: 
 Date:Exhibit 10.13

 Exhibit 10.13 
 Summary Translation of Line of Credit Agreement 
  

			
	Borrower:	  	Beijing Dehaier Medical Technology Company Limited
	Lender:	  	ICBC Beijing

  

	1.	Purpose of Line of Credit. 

 The purpose of the line of credit is to allow the Borrower to finance its working capital needs (including equipment purchases). 
  

	2.	Amount of Line of Credit. 

 RMB10,000,000 
  

	3.	Line of Credit Term. 

 The
line of credit shall run from June 2, 2009 through May 20, 2010. 
  

	4.	Interest rate and method of payment. 

 Interest shall be paid monthly. The interest rate shall be equal to the benchmark interest rate of the People’s Bank plus 5%. 
  

	5.	Repayment date. 

 Payments
of principal are due on November 20, 2009, March 3, 2010 and May 20, 2010 for RMB2,000,000, RMB3,000,000 and RMB5,000,000, respectively. 
  

	6.	Guarantee. 

 The Lender
shall have a mortgage on the building held by Borrower’s affiliated entity, Beijing Dehaier Technology Company Limited. 
  

	7.	Liability for breach of contract. 

 If the Borrower does not repay the loan on the dates set forth above, the Lender shall have the right to deduct such amounts from the Borrower’s bank balance with the Lender and may charge an additional 30% interest penalty.Exhibit 10.14

 Exhibit 10.14 
 ESCROW AGREEMENT 
 This Escrow Agreement is made and
entered into as of the          day of                     , 2010, by and among ANDERSON &
STRUDWICK, INCORPORATED, a Virginia corporation (the “Placement Agent”), DEHAIER MEDICAL SYSTEMS LIMITED, a British Virgin Islands company (the “Company”) and SUNTRUST BANK, N.A. (the “Escrow Agent”). 
 R E C I T A L S: 
 A. The Company proposes to sell a minimum of 1,250,000 ordinary shares and a maximum of 1,500,000 ordinary shares (the “Shares”) of the Company at a price between $7.00 and $9.00 per share on a “best efforts,
minimum/maximum” basis (the “Offering”). 
 B. The Company has retained the Placement Agent, as agent for the
Company to sell the Shares in the Offering, and the Placement Agent has agreed to sell the shares in the Offering as the Company’s agent. 
 C. The Escrow Agent is willing to hold the proceeds of the Offering in escrow pursuant to this Agreement. 
 NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements contained in this Agreement, it is hereby agreed as follows: 
 1. Establishment of the Escrow Agent. Contemporaneously herewith, the parties have established a non-interest-bearing account with
the Escrow Agent, which escrow account is entitled “Dehaier Medical Systems Limited IPO Escrow Account” (the “Escrow Account”). The Placement Agent will transfer funds directly to the Escrow Agent as directed by its customers and
will instruct other purchasers of the Shares to make checks payable to “SunTrust Bank – Dehaier Medical Systems Limited IPO Escrow Account.” 
 2. Escrow Period. The escrow period (the “Escrow Period”) shall begin with the commencement of the Offering and shall terminate upon the earlier to occur of the following dates:

 (a) the date on which the Escrow Agent confirms that it has received in the Escrow Account gross proceeds of
$            , representing the funds necessary to purchase the Shares (the “Investment Amount”); 
 (b)                     , 2010; or 
 (c) the date on which the Placement Agent and the Company notify the Escrow Agent in writing that the Offering has been terminated.

 During the Escrow Period, the Company is aware and understands that it is not entitled to any funds received into escrow and
no amounts deposited in the Escrow Account shall become the property of the Company or any other entity, or be subject to the debts of the Company or any other entity. 
 3. Deposits into the Escrow Account. The Placement Agent agrees that it shall deliver to the Escrow Agent for deposit in the Escrow Account all monies received from purchasers of the Shares by noon
of the next business day after receipt together with a written account of each sale, which account shall set forth, among other things, (i) the purchaser’s name and address, (ii) the number of Shares purchased by the purchaser,
(iii) the amount paid therefor by the purchaser, (iv) whether the consideration received from the purchaser was in the form of a check, draft or money order, and (v) the purchaser’s social security or tax identification number.
The Escrow Agent agrees to hold all monies so deposited in the Escrow Account (the “Escrow Amount”) for the benefit of the parties hereto until authorized to disburse such monies under the terms of this Agreement. 
 4. Disbursements from the Escrow Account. In the event the Escrow Agent has not received the Investment Amount prior to the
termination of the Escrow Period, or if the Placement Agent and the Company notify the Escrow Agent that the Offering has been terminated, the Escrow Agent shall promptly refund to each purchaser the amount received from the purchaser, without
deduction, penalty, or expense to the purchaser, and the

 
Escrow Agent shall notify the Company and the Placement Agent of its distribution of the funds. The purchase money returned to each purchaser shall be free and clear of any and all claims of the
Company or any of its creditors. 
 In the event the Escrow Agent has received the Investment Amount prior to termination of the
Escrow Period, on the Closing Date (as defined in Section 8), the Escrow Agent shall disburse the Escrow Amount pursuant to the provisions of Section 6, provided, however, in no event will the Escrow Amount be released to the
Company until such amount is received by the Escrow Agent in collected funds. For purposes of this Agreement, the term “collected funds” shall mean all funds, including fed funds, received by the Escrow Agent which have cleared normal
banking channels. 
 5. Collection Procedure. 
 (a) The Escrow Agent is hereby authorized to deposit each check in the Escrow Account. 
 (b) In the event any check paid by a purchaser and deposited in the Escrow Account shall be returned, the Escrow Agent shall notify the
Placement Agent by telephone of such occurrence and advise it of the name of the purchaser, the amount of the check returned, and any other pertinent information. The Escrow Agent shall then transmit the returned check directly to the purchaser and
shall transmit the statement previously delivered by the Placement Agent relating to such purchase to the Placement Agent. 
 (c) If the Company rejects any purchase of Shares for which the Escrow Agent has already collected funds, the Escrow Agent shall promptly issue a refund check to the rejected purchaser. If the Placement Agent rejects any purchase for which
the Escrow Agent has not yet collected funds but has submitted the purchaser’s check for collection, the Escrow Agent shall promptly issue a check in the amount of the purchaser’s check to the rejected purchaser after the Escrow Agent has
cleared such funds. If the Escrow Agent has not yet submitted a rejected purchaser’s check for collection, the Escrow Agent shall promptly remit the purchaser’s check directly to the purchaser. 
 6. Delivery of Escrow Account. 
 (a) Prior to the Closing (as defined in Section 8 of this Agreement), the Placement Agent and the Company shall provide the Escrow Agent with a statement, executed by each party, containing the
following information: 
 (i) The total number of Shares sold by the Placement Agent directly to purchasers and a list of each
purchaser, and the number of Shares purchased by such purchaser, and specification of the manner in which the Shares should be issued; and 
 (ii) A calculation by the Placement Agent and the Company as to the manner in which the Escrow Account should be distributed to the Company and the Placement Agent and in the event of oversubscription or
rejection of certain purchasers, the aggregate amount to be returned to individual purchasers and a listing of the exact amount to be returned to each such purchaser. 
 The Escrow Agent shall hold the Escrow Account and distribute it in accordance with the above-described statement on the date of Closing or such later date that it receives the above-described statement.

 (b) Upon termination of the Offering by the Company or the Placement Agent for any reason, the Escrow Agent shall return to
the purchasers who contributed to the Escrow Account the exact amount contributed by them. 
 7. Investment of Escrow
Account. The Escrow Agent shall deposit funds received from purchasers in the Escrow Account, which shall be a non-interest-bearing bank account at SunTrust Bank. 
  

 2 

 8. Closing Date. The “Closing” shall be the date of closing of the
Offering, and the “Closing Date” shall be the date on or subsequent to the date on which the Escrow Agent has received the Investment Amount that is designated to the Escrow Agent by the Placement Agent and the Company as the Closing Date.

 9. Compensation of Escrow Agent. The Company shall pay the Escrow Agent a fee for its services hereunder in an amount
equal to                                         
Dollars ($            ), which amount shall paid on the Closing Date. In the event the Offering is canceled for any reason, the Company shall pay the Escrow Agent its fee within ten
(10) days after the Escrow Amount is refunded to purchasers. No such fee or any other monies whatsoever shall be paid out of or chargeable to the funds on deposit in the Escrow Account. 
 10. Disbursement into Court. If, at any time, there shall exist any dispute between the Company, the Placement Agent and/or the
purchasers with respect to the holding or disposition of any portion of the Escrow Amount or any other obligations of the Escrow Agent hereunder, or if at any time the Escrow Agent is unable to determine, to the Escrow Agent’s sole
satisfaction, the proper disposition of any portion of the Escrow Amount or the Escrow Agent’s proper actions with respect to its obligations hereunder, or if the Company and the Placement Agent have not within 30 days of the furnishing by the
Escrow Agent of a notice of resignation appointed a successor Escrow Agent to act hereunder, then the Escrow Agent may, in its sole discretion, take either or both of the following actions: 
 (a) suspend the performance of any of its obligations under this Escrow Agreement until such dispute or uncertainty shall be resolved to the
sole satisfaction of the Escrow Agent or until a successor Escrow Agent shall have been appointed (as the case my be); provided however, that the Escrow Agent shall continue to hold the Escrow Amount in accordance with Section 7 hereof;
and/or 
 (b) petition (by means of an interpleader action or any other appropriate method) any court of competent jurisdiction
in Richmond, Virginia, for instructions with respect to such dispute or uncertainty, and pay into court all funds held by it in the Escrow Account for holding and disposition in accordance with the instructions of such court. 
 The Escrow Agent shall have no liability to the Company, the Placement Agent or any other person with respect to any such suspension of
performance or disbursement into court, specifically including any liability or claimed liability that may arise, or be alleged to have arisen, out of or as a result of any delay in the disbursement of funds held in the Escrow Account or any delay
in or with respect to any other action required or requested of the Escrow Agent. 
 11. Duties and Rights of the Escrow
Agent. The foregoing agreements and obligations of the Escrow Agent are subject to the following provisions: 
 (a) The
Escrow Agent’s duties hereunder are limited solely to the safekeeping of the Escrow Account in accordance with the terms of this Agreement. It is agreed that the duties of the Escrow Agent are only such as herein specifically provided, being
purely of a ministerial nature, and the Escrow Agent shall incur no liability whatsoever except for negligence, willful misconduct or bad faith. 
 (b) The Escrow Agent is authorized to rely on any document believed by the Escrow Agent to be authentic in making any delivery of the Escrow Account or the certificates representing the Shares. It shall
have no responsibility for the genuineness or the validity of any document or any other item deposited with it and it shall be fully protected in acting in accordance with this Agreement or instructions received. 
 (c) The Company and the Placement Agent hereby waive any suit, claim, demand or cause of action of any kind which they may have or may
assert against the Escrow Agent arising out of or relating to the execution or performance by the Escrow Agent of this Agreement, unless such suit, claim, demand or cause of action is based upon the gross negligence, willful misconduct, or bad faith
of the Escrow Agent. 
  

 3 

 12. Notices. It if further agreed as follows: 
 (a) All notices given hereunder will be in writing, served by registered or certified mail, return receipt requested, postage prepaid, or by
hand-delivery, to the parties at the following addresses: 
 to the Company: 
 Dehaier Medical Systems Limited 
 1223 Epoch Center 
 No. 31 Zi Zhu Yuan Road 
 Haidian District 
 Beijing 100089 
 People’s Republic of China 
 Attention: Ping Chen, Chief Executive Officer 
 to the Placement Agent: 
 Anderson & Strudwick, Incorporated

 707 East Main Street, 20th Floor 
 Richmond, Virginia 23219 
 Attention: L. McCarthy Downs, III 
 Facsimile: (804) 648-3404 
 with copy to: 
 Kaufman & Canoles, P.C. 
 Three James Center 
 1051 East Cary Street 
 12th Floor 
 Richmond, Virginia 23219 
 Attention: Bradley A. Haneberg, Esq. 
 to the Escrow Agent: 
 SunTrust Bank, N.A. 
 919 East Main Street 
 7th Floor 
 Richmond, Virginia 23219 
 Attention: Matthew Ward 
 13. Miscellaneous. 
 (a) This Agreement shall be binding upon, inure to the benefit of and be enforceable by the parties hereto and their respective successors and assigns. 
 (b) If any provision of this Agreement shall be held invalid by any court of competent jurisdiction, such holding shall not invalidate any other provision hereof. 
 (c) This Agreement shall be governed by the applicable laws of the Commonwealth of Virginia. 
 (d) This Agreement may not be modified except in writing signed by the parties hereto. 
 (e) All demands, notices, approvals, consents, requests and other communications hereunder shall be given in the manner provided in this
Agreement. 
 (f) This Agreement may be executed in one or more counterparts, and if executed in more than one counterpart, the
executed counterparts shall together constitute a single instrument. 
 [Dehaier Medical Systems Limited Escrow Agreement
Execution Page Follows] 
  

 4 

 [Dehaier Medical Systems Limited Escrow Agreement Execution Page] 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed in their respective names, all as of the date first
above written. 
  

			
	ANDERSON & STRUDWICK, INCORPORATED
		
	By:	 	  

		 	L. McCarthy Downs, III
		 	Senior Vice President
	
	DEHAIER MEDICAL SYSTEMS LIMITED
		
	By:	 	  

	Name:	 	Ping Chen
	Title:	 	Chief Executive Officer
	
	SUNTRUST BANK, N.A.
		
	By:	 	  

	Name:	 	Matthew Ward
	Title:	 	Trust Officer

  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]